Niagen Bioscience, Inc.
Moat Score — Niagen Bioscience, Inc.
Total Moat Score
14 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 4 / 5 | Niagen Bioscience holds roughly 30 patents on nicotinamide riboside (NR) chemistry, several exclusively licensed from Cornell, the University of Iowa, and Kansas State, giving it a legitimate claim as the clinically-backed originator of the NR/NAD+ precursor category. This IP estate, plus the Tru Niagen brand built on it, is real but narrower than a diversified pharma patent portfolio. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | The company has no structural low-cost position; it depends entirely on a single third-party manufacturer, W.R. Grace, for food-grade NRC, and outsources finished-dose manufacturing, leaving little room for proprietary production cost advantages over larger, more vertically integrated supplement makers. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | Patent protection on NR lets Tru Niagen command premium pricing versus generic NAD+ supplements, supported by clinical studies competitors using unpatented ingredients cannot cite. That power is now under pressure after the FDA's 2025 ruling cleared the rival NMN pathway for lawful sale. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | There is essentially no network effect: Tru Niagen's value to one customer does not increase because other customers buy it, beyond modest community/influencer word-of-mouth typical of any direct-to-consumer wellness brand. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | A subscribe-and-save purchasing habit creates mild reorder inertia for existing Tru Niagen customers, but the underlying active ingredient is substitutable with NMN-based or other longevity products, so true switching costs for consumers are low. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | The NAD+ precursor supplement niche is growing but increasingly crowded, especially now that NMN rivals face no FDA dietary-ingredient barrier; at $129 million in net sales the market is not naturally limited enough to deter well-funded new entrants. |